$TECX SEC Filings

Gave up 525 shares to cover exercise price or tax ($12.4K)

Gave up 444 shares to cover exercise price or tax ($10.5K) · Sold 536 shares ($12.3K)

Gave up 411 shares to cover exercise price or tax ($9.73K)

Gave up 520 shares to cover exercise price or tax ($12.3K)

Gave up 1,545 shares to cover exercise price or tax ($36.6K)

Tectonic Therapeutic Announces Favorable Phase 1 Safety, Tolerability and PK Results for TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT)

Granted 24,250 Employee Stock Option (Right to Buy)

Granted 21,000 Employee Stock Option (Right to Buy)

Granted 17,750 Employee Stock Option (Right to Buy)

Granted 24,250 Employee Stock Option (Right to Buy)

Granted 69,250 Employee Stock Option (Right to Buy)

Received 43 shares by exercise or conversion ($633) · Sold 43 shares ($1.57K)

Received 43 shares by exercise or conversion ($633) · Sold 43 shares ($1.51K)

Received 172 shares by exercise or conversion ($2.53K) · Sold 172 shares ($6.02K)